Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis
Titel:
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis
Auteur:
Bringhen, Sara Pour, Ludek Vorobyev, Vladimir Vural, Filiz Warzocha, Krzysztof Benboubker, Lotfi Koh, Youngil Maisnar, Vladimir Karlin, Lionel Pavic, Michel Campana, Frank Le Guennec, Solenn Menas, Fatima van de Velde, Helgi Richardson, Paul G.